Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
Abstract
Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
Keywords
extracellular vesicles;SARS-CoV-2;targeted delivery;
Data
| Language: | English |
|---|---|
| Year of publishing: | 2022 |
| Typology: | 1.03 - Short Scientific Article |
| Organization: | UNG - University of Nova Gorica |
| UDC: | 577 |
| COBISS: |
104572419
|
| ISSN: | 2329-0501 |
| Views: | 673 |
| Downloads: | 0 |
| Average score: | 0 (0 votes) |
| Metadata: |
|
Other data
| URN: | URN:SI:UNG |
|---|---|
| Type (COBISS): | Not categorized |
| Pages: | str. 41-42 |
| Issue: | ǂVol. ǂ25 |
| Chronology: | Jun. 2022 |
| DOI: | 10.1016/j.omtm.2022.02.003 |
| ID: | 15014142 |
Recommended works:
Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
2022,
no subtitle data available
Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain
2021,
no subtitle data available
Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutralization assay
2021,
no subtitle data available
Nanobodies
2018,
flexible structures for biotechnological applications
Nanomedicine and immunotherapy
2020,
a step further towards precision medicine for glioblastoma